HCA Healthcare (NYSE:HCA) EVP Michael Schlosser Sells 1,200 Shares of Company Stock

HCA Healthcare, Inc. (NYSE:HCA) EVP Michael Schlosser sold 1,200 shares of the stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $494.65, for a total transaction of $593,580.00. Following the completion of the sale, the executive vice president owned 1,443 shares of the company’s stock, valued at approximately $713,779.95. This trade represents a 45.40% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $494.44 on Friday. The company has a 50-day simple moving average of $443.66 and a two-hundred day simple moving average of $445.25. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The stock has a market capitalization of $103.28 billion, a PE ratio of 16.38, a price-to-earnings-growth ratio of 1.56 and a beta of 1.11.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, beating the consensus estimate of $6.65 by $0.57. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The business had revenue of $19.85 billion during the quarter, compared to analysts’ expectations of $19.33 billion. During the same period in the previous year, the business posted $6.96 EPS. The business’s quarterly revenue was up 3.6% compared to the same quarter last year. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 30.15 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s payout ratio is 10.34%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in HCA. BlackRock Inc. acquired a new stake in HCA Healthcare during the 2nd quarter worth approximately $5,069,974,000. Wellington Management Group LLP raised its stake in shares of HCA Healthcare by 20.5% in the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after buying an additional 799,761 shares in the last quarter. Darsana Capital Partners LP boosted its position in HCA Healthcare by 46.7% during the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after purchasing an additional 350,000 shares during the last quarter. Legal & General Group Plc acquired a new position in shares of HCA Healthcare during the second quarter valued at about $410,992,000. Finally, Jupiter Topco LLC bought a new stake in shares of HCA Healthcare during the second quarter valued at approximately $371,138,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on HCA. Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a research note on Monday, July 27th. JPMorgan Chase & Co. dropped their price objective on HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a report on Thursday, August 20th. Wall Street Zen raised HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. Royal Bank Of Canada upped their price target on HCA Healthcare from $496.00 to $521.00 and gave the company an “outperform” rating in a research report on Friday, October 30th. Finally, Bank of America upped their price target on HCA Healthcare from $450.00 to $500.00 and gave the company a “neutral” rating in a research note on Wednesday, October 28th. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $480.13.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Investors have welcomed expectations that a Democratic-controlled Congress could provide a policy tailwind for hospitals. However, the anticipated relief is not yet enacted and still depends on legislative and funding steps. HCA Healthcare Gains Policy Tailwind
• Positive Sentiment: HCA is expanding AI tools, with its nurse handoff technology heading to 100 hospitals and ambient AI expected to reach 10,000 physicians by year-end. These deployments could support workflow efficiency. AI nurse handoff tool
• Positive Sentiment: Analyst and technical coverage is supportive: Truist reaffirmed its Buy rating, while Zacks highlighted earnings growth, price strength and a bullish moving-average signal. Truist reaffirms Buy rating Zacks stock outlook
• Neutral Sentiment: HCA completed a $6.5 billion senior notes offering. The report confirms the financing but gives limited detail on its use or effect on borrowing costs. Senior notes offering
• Neutral Sentiment: HCA’s AI chief emphasized that delaying a rollout can be appropriate, suggesting a measured approach that may limit near-term adoption while managing implementation risks. HCA AI rollout strategy
• Negative Sentiment: One report flagged potential payer pressure in HCA’s 2027 outlook, a concern for future hospital reimbursement and margins. Payer pressure outlook
• Negative Sentiment: Pomerantz LLP said it is investigating investor claims involving HCA. The announcement provides no findings, but the inquiry may create a legal overhang. Investor investigation announcement

HCA Healthcare Company Profile

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine.

The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices.

Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.